# Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

> **NCT07700225** · — · RECRUITING · sponsor: **Virginia Commonwealth University** · enrollment: 1000 (estimated)

## Conditions studied

- DM1
- Myotonic Dystrophy
- Myotonic Dystrophy 1
- Myotonic Dystrophy Type 1
- Myotonic Dystrophy Type-1
- Myotonic Dystrophy, Type 1 (DM1)
- Myotonic Muscular Dystrophy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07700225
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2032-12
- **Final completion:** 2032-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-09-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07700225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07700225, "Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07700225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*